Virtus ETF Advisers’s HUMANIGEN, INC. HGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-36,572
Closed -$110K 491
2022
Q1
$110K Sell
36,572
-2,168
-6% -$5.8K 0.05% 288
2021
Q4
$144K Buy
38,740
+28,385
+274% +$166K 0.05% 358
2021
Q3
$61K Sell
10,355
-546
-5% -$7.67K 0.03% 394
2021
Q2
$189K Sell
10,901
-14,205
-57% -$259K 0.08% 372
2021
Q1
$480K Buy
25,106
+439
+2% +$8.01K 0.2% 152
2020
Q4
$432K Buy
+24,667
New +$295K 0.18% 145

Other funds holding HGEN

Virtus ETF Advisers's HGEN Position: Q2 2022 in Review

Virtus ETF Advisers sold out of HUMANIGEN, INC. (HGEN) in Q2 2022, closing a stake of 36,572 shares — an estimated $110K sold.

Virtus ETF Advisers first reported a position in HGEN in Q4 2020 and held it in 6 quarters. The position peaked at $480K in Q1 2021. 65 funds tracked by Wall St. Rank hold HGEN as of Q2 2022.

  • Virtus ETF Advisers reported no remaining HUMANIGEN, INC. position as of Q2 2022 after selling out during the quarter.
  • Virtus ETF Advisers sold 36,572 HUMANIGEN, INC. shares in Q2 2022, an estimated $110K.
  • Virtus ETF Advisers first reported a position in HUMANIGEN, INC. in Q4 2020 and held it in 6 quarters.
  • Virtus ETF Advisers's HUMANIGEN, INC. position peaked at $480K in Q1 2021.
  • 65 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q2 2022.

Based on Virtus ETF Advisers's 13F filing for Q2 2022, filed 12 Aug 2022.